Back

Antiplatelet effects of intraoperative administration of ticagrelor versus clopidogrel in patients undergoing one-stop hybrid coronary revascularization: a single-center randomized controlled trial

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Treatment of coronary artery disease, other Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Qian Zhang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Doctor I. Lazareva (Minsk, BY)
Abstract
Presentation thumbnail
Miss S. Kruchinova (Krasnodar, RU)
Abstract Slides
Presentation thumbnail
Doctor T. Popov (Sremska Kamenica, RS)
Abstract Slides
Presentation thumbnail
Doctor M. Aggarwal (Gainesville, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Treatment of coronary artery disease, other

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of the antiplatelet effect of different p2y12 inhibitors using two methods at 30 and 120 minutes after oral loading in the cardiac catheterization laboratory
21 March 2026
thumbnail
Congress Presentation
Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure
4 April 2022
thumbnail
Congress Presentation
Ticagrelor-based dual antiplatelet therapy versus aspirin monotherapy after CABG: a systematic review and meta-analysis of randomized controlled trials
30 August 2026
thumbnail
Congress Presentation
Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources